NRx Pharmaceuticals Shares Rise as FDA Completes Initial Review of Ketamine Product

Shares of NRx Pharmaceuticals (NASDAQ: NRXP) rose Friday after the company said the U.S. Food and Drug Administration completed its first-cycle review... Read More

The post NRx Pharmaceuticals Shares Rise as FDA Completes Initial Review of Ketamine Product appeared first on citybiz.